-
781
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
Published 2025-02-01“…IntroductionStimulator of interferon response cGAMP interactor (STING) is essential for both innate and adaptive immunity. …”
Get full text
Article -
782
CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation
Published 2025-02-01“…This hypersialylation and hyperfucosylation were particularly induced by activation with anti-IgM and interferon-γ (IFN-γ). Transcriptome analysis suggested that naïve-like CD21low B cells possess a comprehensively reorganised glycosylation machinery, with anti-IgM/IFN-γ having the potential to initiate these changes in vitro.ConclusionCD21low B cells are hypersialylated and hyperfucosylated. …”
Get full text
Article -
783
Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis
Published 2025-01-01“…Here, we investigated the relationship between inflammatory cytokines and cortical thickness in patients with ALS.MethodsWe evaluated 51 patients with ALS for inflammatory cytokines including interleukin (IL)-4, interferon (IFN)-α, IL-1β, IL-2, IL-5, IL-12, tumor necrosis factor (TNF)-α, IL-6, IL-10, IL-8, IL-17, and IFN-γ and analyzed the correlation between these indicators and the ALS functional rating scale-revised (ALSFRS-R) score or disease progression rate (ΔFS score). …”
Get full text
Article -
784
homeRNA self-blood collection enables high-frequency temporal profiling of presymptomatic host immune kinetics to respiratory viral infection: a prospective cohort studyResearch in...
Published 2025-02-01“…This is followed by a rapid induction of many interferon-stimulated genes (ISGs), concurrent to onset of viral shedding and increase in nasal viral load and symptom burden. …”
Get full text
Article -
785
Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells
Published 2025-03-01“…Given that the tumor-intrinsic response to interferon-γ (IFN-γ) is a key determinant of immunotherapy efficacy, we investigated whether and how glutamine deprivation in cancer cells affects their response to IFN-γ. …”
Get full text
Article -
786
Détection de différents rétrovirus chez des primates non-humains infectés par STLV-1 ou SFV et pathologie viro-induite
Published 2015-03-01“…Un traitement expérimental associant Combivir (AZT) et viraferon (interféron-alpha) et qui est utilisé chez les patients ATL chronique ou aiguë fut proposé. …”
Get full text
Article -
787
γδ T Cell‐mediated Tumor Immunity is Tightly Regulated by STING and TGF‐β Signaling Pathways
Published 2025-01-01“…This activation leads to interferon‐gamma (IFN‐γ) production and consequent tumor surveillance. …”
Get full text
Article -
788
FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma
Published 2025-02-01“…RNA-seq analysis further indicated that FAM210B plays a role in regulating innate immune-related signaling pathways in LUAD cells, particularly involving the production of type I interferon (IFN-α/β). Specifically, FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression, leading to the inhibition of proliferation and migration of LUAD cells. …”
Get full text
Article -
789
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial
Published 2025-02-01“…Notably, baseline high ImmuneScore, immune cell infiltration, and enrichment of interferon-related pathways correlated with pCR. Comparison of pre-neoadjuvant and post-surgery data revealed that the pCR group treated with this novel regimen exhibited an upregulation of distinct immune cell subsets, thereby activating the tumor microenvironment. …”
Get full text
Article -
790
Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus
Published 2025-01-01“…Our findings reveal significant species‐specific similarities and differences in immune responses and metabolic regulation, with proteins like Interferon‐Stimulated Gene 15 (ISG15) and Retinoic Acid‐Inducible Gene I (RIG‐I) playing crucial roles in the anti‐CHIKV defense. …”
Get full text
Article -
791
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Published 2025-01-01“…Patients treated with dabrafenib plus trametinib as adjuvant therapy had the longest relapse-free survival (RFS) (median: 8.3 months), followed by those treated with interferon (4.1 months) and nivolumab (1.9 months) (p = 0.002). …”
Get full text
Article -
792
Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity
Published 2025-01-01“…Plasma ACBP levels were negatively correlated with biomarkers of T and NK cell responses interferon-γ, tumor necrosis factor-α and interleukin-21, independently of age, sex, and severity.ConclusionsCirculating ACBP levels can be considered a biomarker of COVID-19 severity linked to inflammation. …”
Get full text
Article -
793
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti...
Published 2023-01-01“…Furthermore, RNA sequencing revealed nuclear factor-kB (NF-κB) pathway induction as a response to CI-994 treatment, followed by transglutaminase 2 (TGM2) expression, which enhanced inflammatory cytokine secretion. We further show interferon-γ release and cell surface expression of engulfment (‘eat-me’) signals (such as calreticulin). …”
Get full text
Article -
794
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
Published 2025-02-01“…CAR-CIK cell cytokine signature showed significantly increased secretion of effector molecules like interferon-γ, perforin and granulysin, and lower secretion of Th2 cytokines IL-2, IL-4 and IL-10. …”
Get full text
Article -
795
Systemic Treatment of Vitreous Inflammation
Published 2012-01-01“…The classes of drugs are ever expanding and include corticosteroids, antimetabolites, alkylating agents, T-cell and calcineurin agents, biologic agents, and interferons. Each class of systemic therapy for non-infectious vitreous inflammation is reviewed. …”
Get full text
Article -
796
Altered Protein Structures and Neoepitopes in Lupus Neutrophils From Dysregulated Splicing of Messenger RNA
Published 2025-01-01“…Only a small number of dysregulated splicing events were more pronounced in patients with active disease or with high type I interferons but were not detected in SARS‐CoV2–infected individuals, who also had high type I interferons. …”
Get full text
Article -
797
Viruses Seen by Our Cells: The Role of Viral RNA Sensors
Published 2018-01-01“…This recognition leads to the induction of type 1 interferons (IFNs) as well as inflammatory cytokines and chemokines. …”
Get full text
Article -
798
Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases
Published 2013-01-01“…Particularly, the regulation of type I interferons (IFNs) production via IDO1 in virus infection is discussed. …”
Get full text
Article -
799
Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
Published 2013-01-01“…Alopecia areata is sometimes triggered by viral infections such as influenza that causes excess production of interferons (IFN). IFN-γ is one of the key factors that lead to the collapse of immune privilege. …”
Get full text
Article -
800
Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?
Published 2019-03-01“…In MS treatment, disease modifying therapies (DMTs) are essential to reduce disease progression by suppressing the inflammatory response responsible for promoting lesion formation. Injectable (Interferons and Glatiramer acetate) and infusion (Natalizumab, Alemtuzumab) therapies are both effective however rather exhausting for patients. …”
Get full text
Article